Largest Trial So Far in Mesothelioma Disappoints – Medscape News
Filed in Mesothelioma News on Sep.30, 2011
September 29, 2011 (Stockholm, Sweden) — The largest randomized phase 3 study ever conducted in patients with advanced malignant pleural mesothelioma has failed; no survival benefit was seen with vorinostat (Zolinza, Merck & Co). “Despite the negative …
View full post on mesothelioma – Bing News

Leave a Reply
You must be logged in to post a comment.